• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RELIANCE 4-FRONT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RELIANCE 4-FRONT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) Back to Search Results
Model Number 0673
Device Problems Pocket Stimulation (1463); Device Dislodged or Dislocated (2923)
Patient Problems Muscle Stimulation (1412); No Consequences Or Impact To Patient (2199); No Code Available (3191)
Event Date 12/18/2019
Event Type  Injury  
Manufacturer Narrative
The lead is expected to be returned for analysis.This report will be updated upon completion of investigation.
 
Event Description
It was reported during ongoing use, the ventricle lead was dislocated, and causing diaphragmatic stimulation.The lead was explanted and replaced.There was no harm to the patient, and it was also indicated that the patient did not receive any inappropriate therapy.The patient is also not pacemaker dependent.The new lead showed good sensing values, and the old lead will be returned for analysis.
 
Event Description
It was reported during ongoing use, the (rv) right ventricle lead was dislocated, and causing diaphragmatic stimulation.Therefore, the lead was explanted and replaced.The new rv lead showed normal sensing values.There was no harm to the patient, and it was also reported that the patient did not receive any inappropriate therapy.Additionally, it was indicated that the patient is not pacemaker dependent.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, the lead was received with the helix in an extended position.Visual inspection revealed no abnormalities, as the lead tip/helix appeared normal.A thorough evaluation of the lead was performed.Testing was completed to assess lead electrical performance and inner/outer insulation integrity.Measurements throughout these tests were within normal limits.Microscopic inspections of the terminal pin assembly, lead body, and electrode tip found no anomalies.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.Laboratory observations and the field report were insufficient to verify dislodgment.The allegation of muscle stimulation is a known inherent risk of the device, which likely occurred due to the dislodgment.The surgery allegation could not be confirmed, as there was no evidence of device damage, defect, or malfunction found.Patient code (b)(4) captures the reportable event of surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RELIANCE 4-FRONT
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key9550672
MDR Text Key173694818
Report Number2124215-2019-27289
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/06/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/03/2021
Device Model Number0673
Device Catalogue Number0673
Device Lot Number107510
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/28/2020
Date Manufacturer Received03/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age84 YR
-
-